Sapio Sciences and ZS partner to advance laboratory digitalization for biopharma R&D and CMC
June 2, 2026
The partnership combines Sapio Platform capabilities with ZS consulting expertise to deliver integrated laboratory solutions BALTIMORE, MD – Sapio Sciences, the AI lab informatics company, today announced a partnership with the management consulting and technology firm ZS. Together, the companies will offer consulting and implementation services supporting Sapio Platform deployments across biopharma R&D and chemistry, manufacturing [...]
Genomics Launches the Mystra AI Platform, Adopted by Industry Giants and Up-and-Coming Biotechs
June 2, 2026
New conversational AI platform leverages the world's largest human genetics database to power target discovery and validation. Mystra AI is the market-leading agent, accessible to all scientists in Research & Development and Business Development & Licensing. 95% of drug candidates in clinical trials fail. Targets with human genetic support are 2.6 times more likely to [...]
SMi Systems announces a non-exclusive collaboration with Luminex
June 2, 2026
LONDON -- SMi Systems announces today the execution of a non-exclusive evaluation collaboration with Luminex Corporation to assess the feasibility of using Luminex beads with SMi's single-molecule imaging platform and to compare SMi's analytical sensitivity with Luminex's current xMAP readers under defined test conditions. The evaluation is initially focused on research activities to validate the potential [...]
June 2, 2026
New genomic services portfolio establishes Zymo as a premier NGS partner, offering end-to-end solutions built on proven technology and deep scientific expertise IRVINE, Calif. -- Zymo Research, a global leader in genomics tools, today announced the launch of Zymo Services, a dedicated portfolio of end-to-end next-generation sequencing (NGS) services. The new offering reflects Zymo's evolution from molecular biology [...]
June 2, 2026
Advanced Delivery. True Empty/Partial/Full Analytics. Greater Confidence for Gene Therapy Developers. Agreement brings together Solid's POLARIS-101™ (AAV-SLB101) next-generation capsid and NanoMosaic's FDA AMT-designated Tessie™ platform to provide gene therapy developers enhanced access to critical technologies for delivery, measurement, and regulatory readiness WALTHAM, Mass. and CHARLESTOWN, Mass. -- Solid Biosciences Inc. and NanoMosaic, Inc. today announced that they [...]
June 2, 2026
San Diego—ASMS 2026—Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling. The collaboration brings together Evosep’s robust liquid chromatography platform with Molecular You’s comprehensive biomarker analysis and interpretation workflows to enable scalable, globally deployable solutions for early disease assessment and proactive health management. At the [...]
June 2, 2026
Helping R&D teams move from raw internal data to cited, defensible scientific decisions in a single governed workflow — setting a new standard for speed, rigor, and provenance in drug discovery and development SAN FRANCISCO -- Microsoft Build 2026 -- Causaly today announced a collaboration with Microsoft at Microsoft Build 2026 that brings scientific computation and scientific interpretation together [...]
June 2, 2026
Collaboration Aims to Accelerate Adoption of EPR Spectroscopy in Structural Biology and Drug Discovery WATERLOO, Ontario -- High Q Technologies, a developer of quantum-enabled electron paramagnetic resonance (EPR) spectroscopy systems, and Creative Biostructure, a structural biology Contract Research Organization, today announced a strategic partnership to support broader adoption of EPR spectroscopy for studying protein dynamics [...]
June 1, 2026
Canton, MA and Cambridge, MA — EquipNet and US Lab Partners have entered a strategic partnership that brings together expertise in laboratory operations. The collaboration is designed to help life science companies reduce operational complexity, improve efficiency, and keep scientific teams focused on advancing research. As laboratories continue to face increasing pressure to do more with [...]
Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability
June 1, 2026
Redefined Column Durability and Method Reliability TORRANCE, Calif. -- Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, today introduced the Endrix Long Life LC column, a new liquid chromatography solution engineered for extended column lifetime and consistent performance in demanding analytical workflows. Designed to withstand [...]

